| Application # | Type | Sponsor | Notes | Product # | Drug Name | Form | Strength | Active Ingredient | Approval Date | Marketing Status | Reference Standard |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 218944 | NDA | SYNDAX | 001 | REVUFORJ | TABLET;ORAL | EQ 25MG BASE | REVUMENIB CITRATE | 2024-11-15 | Prescription | No | |
| 002 | REVUFORJ | TABLET;ORAL | EQ 110MG BASE | REVUMENIB CITRATE | 2024-11-15 | Prescription | No | ||||
| 003 | REVUFORJ | TABLET;ORAL | EQ 160MG BASE | REVUMENIB CITRATE | 2024-11-15 | Prescription | Yes |